Sequential actions of immune effector cells induced by viral activation of dendritic cells to eliminate murine neuroblastoma

Naonori Kawakubo, Sakura Tanaka, Yoshiaki Kinoshita, Tatsuro Tajiri, Yoshikazu Yonemitsu, Tomoaki Taguchi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: In preclinical trails, we reported the antitumor effect of dendritic cells activated with Sendai virus (rSeV/DC) combined with γ-irradiation against neuroblastoma. However, what kind of effector cells for the combined therapy were used to show the antitumor effect was unclear. In this study, we performed radiation and rSeV/DC therapy in vivo and examined the effector cells involved. Methods: Dendritic cells were cultured from bone marrow cells, activated with SeV and administered intratumorally at 106 weekly for 3 weeks. Radiation was administered at 4 Gy/time × 3 times. During the treatment, CD4 + and CD8 + cells and natural killer (NK) cells were removed by antibodies. Results: Complete remission of neuroblastoma was observed in 62.5% of individuals in the combined therapy group. By depleting the effector cells using antibodies, the tumor increased in size from an early stage of treatment in the CD4 + and NK cell-depleted group. In contrast, the tumor increased in size in the late stage of treatment in the CD8 + cell-depleted group. Conclusion: The combination of radiation and rSeV/DC therapy induces different effector cells, depending on the time point during treatment. Level of Evidence: V.

Original languageEnglish
Pages (from-to)1615-1620
Number of pages6
JournalJournal of Pediatric Surgery
Volume53
Issue number8
DOIs
Publication statusPublished - Aug 1 2018

Fingerprint

Virus Activation
Neuroblastoma
Dendritic Cells
Radiation
Natural Killer Cells
Therapeutics
Neoplasm Antibodies
Sendai virus
Group Psychotherapy
Cell- and Tissue-Based Therapy
Bone Marrow Cells
Antibodies
Neoplasms

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Sequential actions of immune effector cells induced by viral activation of dendritic cells to eliminate murine neuroblastoma. / Kawakubo, Naonori; Tanaka, Sakura; Kinoshita, Yoshiaki; Tajiri, Tatsuro; Yonemitsu, Yoshikazu; Taguchi, Tomoaki.

In: Journal of Pediatric Surgery, Vol. 53, No. 8, 01.08.2018, p. 1615-1620.

Research output: Contribution to journalArticle

@article{9b002bc3675446febbca4f4b6080d15d,
title = "Sequential actions of immune effector cells induced by viral activation of dendritic cells to eliminate murine neuroblastoma",
abstract = "Purpose: In preclinical trails, we reported the antitumor effect of dendritic cells activated with Sendai virus (rSeV/DC) combined with γ-irradiation against neuroblastoma. However, what kind of effector cells for the combined therapy were used to show the antitumor effect was unclear. In this study, we performed radiation and rSeV/DC therapy in vivo and examined the effector cells involved. Methods: Dendritic cells were cultured from bone marrow cells, activated with SeV and administered intratumorally at 106 weekly for 3 weeks. Radiation was administered at 4 Gy/time × 3 times. During the treatment, CD4 + and CD8 + cells and natural killer (NK) cells were removed by antibodies. Results: Complete remission of neuroblastoma was observed in 62.5{\%} of individuals in the combined therapy group. By depleting the effector cells using antibodies, the tumor increased in size from an early stage of treatment in the CD4 + and NK cell-depleted group. In contrast, the tumor increased in size in the late stage of treatment in the CD8 + cell-depleted group. Conclusion: The combination of radiation and rSeV/DC therapy induces different effector cells, depending on the time point during treatment. Level of Evidence: V.",
author = "Naonori Kawakubo and Sakura Tanaka and Yoshiaki Kinoshita and Tatsuro Tajiri and Yoshikazu Yonemitsu and Tomoaki Taguchi",
year = "2018",
month = "8",
day = "1",
doi = "10.1016/j.jpedsurg.2017.08.019",
language = "English",
volume = "53",
pages = "1615--1620",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Sequential actions of immune effector cells induced by viral activation of dendritic cells to eliminate murine neuroblastoma

AU - Kawakubo, Naonori

AU - Tanaka, Sakura

AU - Kinoshita, Yoshiaki

AU - Tajiri, Tatsuro

AU - Yonemitsu, Yoshikazu

AU - Taguchi, Tomoaki

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Purpose: In preclinical trails, we reported the antitumor effect of dendritic cells activated with Sendai virus (rSeV/DC) combined with γ-irradiation against neuroblastoma. However, what kind of effector cells for the combined therapy were used to show the antitumor effect was unclear. In this study, we performed radiation and rSeV/DC therapy in vivo and examined the effector cells involved. Methods: Dendritic cells were cultured from bone marrow cells, activated with SeV and administered intratumorally at 106 weekly for 3 weeks. Radiation was administered at 4 Gy/time × 3 times. During the treatment, CD4 + and CD8 + cells and natural killer (NK) cells were removed by antibodies. Results: Complete remission of neuroblastoma was observed in 62.5% of individuals in the combined therapy group. By depleting the effector cells using antibodies, the tumor increased in size from an early stage of treatment in the CD4 + and NK cell-depleted group. In contrast, the tumor increased in size in the late stage of treatment in the CD8 + cell-depleted group. Conclusion: The combination of radiation and rSeV/DC therapy induces different effector cells, depending on the time point during treatment. Level of Evidence: V.

AB - Purpose: In preclinical trails, we reported the antitumor effect of dendritic cells activated with Sendai virus (rSeV/DC) combined with γ-irradiation against neuroblastoma. However, what kind of effector cells for the combined therapy were used to show the antitumor effect was unclear. In this study, we performed radiation and rSeV/DC therapy in vivo and examined the effector cells involved. Methods: Dendritic cells were cultured from bone marrow cells, activated with SeV and administered intratumorally at 106 weekly for 3 weeks. Radiation was administered at 4 Gy/time × 3 times. During the treatment, CD4 + and CD8 + cells and natural killer (NK) cells were removed by antibodies. Results: Complete remission of neuroblastoma was observed in 62.5% of individuals in the combined therapy group. By depleting the effector cells using antibodies, the tumor increased in size from an early stage of treatment in the CD4 + and NK cell-depleted group. In contrast, the tumor increased in size in the late stage of treatment in the CD8 + cell-depleted group. Conclusion: The combination of radiation and rSeV/DC therapy induces different effector cells, depending on the time point during treatment. Level of Evidence: V.

UR - http://www.scopus.com/inward/record.url?scp=85029590059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029590059&partnerID=8YFLogxK

U2 - 10.1016/j.jpedsurg.2017.08.019

DO - 10.1016/j.jpedsurg.2017.08.019

M3 - Article

VL - 53

SP - 1615

EP - 1620

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 8

ER -